Natalia Restrepo Galeano

General Ophthalmologist - Office 614

Education:

Undergraduate: University of Antioquia

Specialization: Pontifical Bolivarian University

Member of:

Society Colombiana de Oftalmología

Sandiego Ophthalmology Clinic Academic Committee

Publications he has made:

Event name ARVO 2010 Annual Meeting. The Future of Eye and Vision Research. May 2 – 6, 2010. Fort Lauderdale, Fl.
Poster session # 424. Diabetic Retinopathy. Poster Presenter4233. Comparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upMonday, May 03, 2010, 8:30 AM - 8:45 AM
Paper session # 220. AMD Clinical Trial. Paper Co-Author1250. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 03, 2010, 8:30 AM - 8:45 AM.

/span>
Event name ARVO 2010 Annual Meeting. IX Annual Meeting Pan-American Research Day May 1, 2010. Fort Lauderdale, Fl.
2010 Annual Meeting: Poster PresenterComparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upSaturday, May 01, 2010, 3:35 PM - 3:40 PM* Recipient of the 2010 Tyson ARVO Clinical Research Initiative Scholarship Award.
Event Name Joint Meeting of the 29th PAAO Congress and the 113th AAO Annual Meeting Oct 24-27, 2009 San Francisco, CA
2009 Joint Meeting: Poster Co-AuthorPO248 - Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From a Multicenter Study Group at 24 MonthsRoom: South, Hall A10/25/2009: 12 :30 PM - 2:00 PM* 2009 Best Poster Award
2009 Joint Meeting: Poster Co-AuthorPO261 – Bevacizumab Primary IVT for Diffuse Diabetic Macula Edema: Results of a 24-Month Retina Collaborative Study GroupRoom: South, Hall A10/25/2009: 12:30 PM - 2:00 PM
Name of the event V International Congress of Ophthalmology Clofan 5 - 7 August 2009 Medellín, Colombia
Co-Author Paper Primary IVT Bevacizumab for Diffuse Diabetic Macular Edema: Results of a 24-Month Collaborative Retina Study GroupAugust 07, 2009, 10:30 AM - 10:45 AM
Event name ARVO 2009 Annual Meeting. Reducing Disparities in Eye Disease and Treatment. May 3 – 7, 2009 Fort Lauderdale, Fl
Paper session # 250. Diabetic Retinopathy III. Poster Co-Author1680. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 04, 2009, 3:00 PM - 3:15 PM
< span>
Event name The 112th AAO Annual Meeting Subspecialty Day Retina. Nov 7 – 8, 2008 Atlanta – GA• 2008 Joint Meeting: Paper Co-AuthorAvastin in the Management of Diabetic Macular EdemaSection XII: Diabetic Retinopathy10/08/2008: 3:44 PM

Participation in conferences:

Project name: Primary Intravitreal Bevacizumab for Diffuse Diabetic
Macular Edema: The Pan-American Collaborative Retina
Study Group at 24 Months
Publication Date September 2009
Journal Title Ophthalmology
Project Name Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in AMD at 24 Months: The Pan-American Collaborative Retina Study Group
Acceptance Date January 28, 2010 (Submission Ms. No. 2009-1328R2)
Title of the Journal Ophthalmology